CAS 504-24-5 - Factory, Suppliers, Manufacturers from China

CAS 504-24-5, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

4-Aminopyridine CAS 504-24-5 Assay ≥99.5% (HPLC) Factory
Read More

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

tert-Butylhydroquinone (TBHQ) CAS 1948-33-0 Purity >99.5% (GC) Food Antioxidant Factory

Top Selling Products

Related Blog
Reviews

The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021 As the world’s second largest medical market, ...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...

2022.11.23 19:34:48
2022.11.06 11:25:43
2022.08.30 21:02:32
2022.08.29 19:43:37
2022.04.22 21:08:04
2022.02.06 11:18:03

CAS 504-24-5 - Factory, Suppliers, Manufacturers from China

Related Products

4-Aminopyridine CAS 504-24-5 Assay ≥99.5% (HPLC) Factory

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

tert-Butylhydroquinone (TBHQ) CAS 1948-33-0 Purity >99.5% (GC) Food Antioxidant Factory

Top Selling Products

Fmoc-Asn(Trt)-OH CAS 132388-59-1 Nα-Fmoc-Nγ-Trityl-L-Asparagine Purity >99.0% (HPLC) Factory

1-Formylpiperazine CAS 7755-92-2 Purity >98.0% (GC)

4-Nitroaniline CAS 100-01-6 Purity >99.0% (GC) Factory High Quality

Methyl 3-(Chlorosulfonyl)-2-Thiophenecarboxylate CAS 59337-92-7 Purity >97.0% (HPLC) Tenoxicam Intermediate Factory

6-Bromoindole CAS 52415-29-9 Purity >99.0% (HPLC) Factory High Quality

Travoprost CAS 157283-68-6 Assay 96.0%~102.0% API Factory High Purity

AMPSO Sodium Salt CAS 102029-60-7 Purity >98.0% (Titration) Biological Buffer Extrapure Factory

1,2-Bis(2-Chloroethoxy)ethane CAS 112-26-5 Purity ≥98.0% (GC)

4'-Fluoropropiophenone CAS 456-03-1 Purity >98.0% (GC)

D-(+)-Xylose CAS 58-86-6 Purity >99.5% (HPLC) Factory High Quality

Piperazine Adipate CAS 142-88-1 Purity >98.0% (T)

Z-Tyr(Bzl)-OH CAS 16677-29-5 Z-O-Benzyl-L-Tyrosine Purity >98.5% (HPLC)

The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

New COVID treatments offer hope

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Paxlovid: what we know about Pfizer's Covid-19 pill

The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

Xi presents award to top scientists

2022.11.23 19:34:48

2022.11.06 11:25:43

2022.08.30 21:02:32

2022.08.29 19:43:37

2022.04.22 21:08:04

2022.02.06 11:18:03

related search